Overview

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Documentation of the effect of SIFROL® on tremor and depression as well as its tolerability in ambulatory patients suffering from idiopathic Parkinson's disease under routine conditions
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Pramipexole